Downstream: Maximizing Investments and Strengthening Systems
Looking downstream, we focus on aligning programmatic and advocacy investments to maximize health outcomes and strengthen primary health care systems. This work includes testing new interventions that target maternal and newborn morbidity and mortality; increasing coverage of key interventions through strengthened primary health care systems; and advancing evidence-based recommendations to accelerate the adoption of innovations by global and country decision-makers.
Our partners help gather, assess, and share critical data on maternal and newborn health to inform policies, and we look for opportunities to maximize health financing to support program implementation. We are also helping develop a standardized set of indicators for health targets and measurements to guide planning, monitoring, and decision-making.
Upstream: Developing Innovative Tools to Address Root Causes of Poor Health
We are investing in non-vaccine tools targeting the time between conception to 2 years of age to shift the mother-fetus and mother-infant trajectory from the vulnerable to the ideal. We focus our investments on three initiatives:
- Optimizing birth outcomes for mothers and newborns.
- Supporting thriving in the community.
- Optimizing prevention and treatment of acute illness.
We use a variety of tools and technologies outside of vaccines, including diagnostics, devices, therapeutics, treatment algorithms and nutritional supplements to support healthy pregnancies and babies. We invest in research and development for vaccines via our other Global Health teams, including Enteric and Diarrheal Diseases; Pneumonia, Malaria, Vaccine Development & Surveillance; and Discovery & Translational Sciences.
In addition to the three initiatives above, our Strategic Data Analysis & Synthesis initiative aggregates all of the data and knowledge generated across our portfolio of investments to inform our priorities and track progress. This initiative helps us understand burden, analyze crosscutting quantitative questions, and model the impact and cost-effectiveness of new tools.
For more about our upstream work, please visit Maternal, Newborn & Child Health Discovery & Tools.